Invests in
Sectors:
Locations:
Min Investment:
$10,000,000.00Max Investment:
$50,000,000.00Target Investment:
$25,000,000.00
Skills
Education
- D-
- D-
Lists including Jack
Investments
Clasp Therapeutics
Total Funding: $150M
Inspirna
Total Funding: $55M
IO Biotech
Total Funding: $150M
ALX Oncology
Total Funding: $170M
Crinetics Pharmaceuticals
Total Funding: $64M
Merus
Total Funding: $150M
Anokion
Total Funding: $78M
Akebia Therapeutics
Total Funding: $88M
ProteinSimple
Total Funding: $74M
Tobira Therapeutics
Total Funding: $31M
Reata Pharmaceuticals
Total Funding: $100M
Alios BioPharma
Total Funding: $74M
Neomend
Total Funding: $30M
MediQuest Therapeutics
Total Funding: $39M
Work Experience
2017
Managing Partner
2017
Consultant
2017 - 2017
2021
Board Member
2021
2021
Board Member
2021
IO Biotech went public on Nasdaq in November 2021 under Ticker IOBT
2020
Board Member
2020
Instil Bio went public on Nasdaq in March 2021 under Ticker TIL
2020
Board Member
2020
ALX Oncology went public on Nasdaq in July 2020 under Ticker ALXO
2018
Chairman / Lead Director
2018
Aligos went public on Nasdaq in October 2020 under Ticker ALGS
Board Member
2017
Harmony Biosciences went public on NASDAQ August 2020 under ticker HRMY
2006 - 2022
Lead Director - Board Member
2006 - 2022
Reata went public on Nasdaq in May 2016 under Ticker RETA. Acquired by Biogen in 2023 for $7.3 BUSD
2019 - 2022
Board Member
2019 - 2022
LumiThera acquired the Maculogix in 2022
2018 - 2020
Board Observer
2018 - 2020
Passage Bio raised 216 MUSD in an IPO on NASDAQ under ticker PASG